Suppression of the onset and progression of collagen-induced arthritis in rats by QFGJS, a preparation from an anti-arthritic Chinese herbal formula |
| |
Authors: | Cai Xiong Zhou Hua Wong Yuen Fan Xie Ying Liu Zhong Qiu Jiang Zhi Hong Bian Zhao Xiang Xu Hong Xi Liu Liang |
| |
Affiliation: | Research and Development Division, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Kowloon, Hong Kong, China. |
| |
Abstract: | QFGJS is an herbal preparation, and its pronounced effectiveness in treating adjuvant-induced arthritis (AIA) has been previously demonstrated. We herein aimed to confirm its anti-arthritic effect on collagen-induced arthritis (CIA) in rats. CIA was established in female Wistar rats with intradermal injection of type II bovine collagen at the base of the tail of animals. CIA rats were treated daily with oral administration of different doses of QFGJS beginning on the day of the induction of arthritis (day 0, the prophylactic treatment) or on the day after the onset of arthritis (day 13, the therapeutic treatment) until day 30. The results showed that prophylactic treatment with QFGJS significantly suppressed the onset of arthritis, and therapeutic treatment with QFGJS markedly reduced paw swelling and ESR levels even in the established CIA. Radiologic and histopathologic changes in the arthritic joints were also significantly reduced in the QFGJS-treated versus vehicle-treated rats. Moreover, the serum levels of pro-inflammatory cytokines TNF-alpha, IL-1beta, and IL-6 were markedly lowered in the QFGJS-treated rats. Hence, our studies demonstrate the quality, safety, and effectiveness of QFGJS as an anti-arthritic agent, which makes QFGJS a strong candidate for further clinical trials on rheumatoid arthritis (RA) patients. |
| |
Keywords: | AIA, adjuvant-induced arthritis CFA, complete Freund's adjuvant CIA, collagen-induced arthritis CII, bovine type II collagen CMC, carboxymethylcellulose DMARDs, disease-modifying antirheumatic drugs ELISA, enzyme-linked immunosorbent assay ESR, erythrocyte sedimentation rate GLP, Good Laboratory Practice H& E, hematoxylin and eosin HPLC, high-performance liquid chromatography ICSH, International Council for Standardization in Haematology IFA, incomplete Freund's adjuvant IL, interleukin MMPs, matrix metalloproteinases MT, Mycobacterium tuberculosis NSAIDs, non-steroidal anti-inflammatory drugs PBS, phosphate-buffered saline RA, rheumatoid arthritis SD, Sprague–Dawley S.E.M., standard error of mean SPF, specific-pathogen-free TNF, tumor necrosis factor TPA, 12-O-tetradecanoylphorbol 13-acetate |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|